.
The microarray data from the three stromal cell lines described in this manuscript have been deposited in the "Gene Expression Omnibus" with the following Accession numbers:
Gene expression analysis of embryo-derived stromal cell lines GSM292046 Irradiated EL08-1D2, biological rep 1 GSM292047 Irradiated EL08-1D2, biological rep 2 GSM292048 Irradiated UG26-1B6, biological rep 1 GSM292049 Irradiated UG26-1B6, biological rep 2 GSM292050 Irradiated AM20-1B4 
FGF2 (Blocking Antibody)
Basic fibroblast growth factor (bFGF or FGF2), is a multifunctional growth factor involved in cell growth and in tumor development and progression, and is also a mitogen with prominent angiogenic properties. bFGF binds to all four FGF receptors, which induces receptor dimerisation and autophosphorylation, allowing binding and activation of downstream targets including FRS2, PLC and Crk.
2.5μg/ ml Mouse AbCam 41
Cathepsin K (Chemical Inhibitor)
Cathepsin K expression is stimulated by inflammatory cytokines, and is able to catabolise elastin, collagen, and gelatin to function in bone and cartilage resorption 50nM Human/ Mouse Calbioc hem 47
FGF9 (Blocking Antibody)
Fibroblast growth factor 9 is a secreted factor that exhibits a growth-stimulating effect on cultured glial cells. Murine FGF9 expression is dependant on Sonic hedgehog (Shh) signaling and male-to-female sex reversal is observed in its absence, suggesting a role in testicular embryogenesis. 
CCL2 (Blocking Antibody)
Chemokine (C-C motif) ligand 2 binds to chemokine receptors CCR2 and CCR4. It displays chemotactic activity for monocytes and basophils and has been implicated in diseases characterised by monocytic infiltrates (e.g. psoriasis, rheumatoid arthritis and atherosclerosis). Additionally CCL2 is a downstream member of the VEGF/VEGFR2 signalling pathway and may be involved in cell proliferation via NFκβ and AP-1.
5μg/m l Mouse R&D Systems 64
IL6 (Blocking Antibody)
Interleukin 6 is stimulates the IL-6 receptor signalling pathway to directly activate JAK1 signalling whilst cleaving ADAM 10 and 17 proteins. IL-6 binding can also indirectly activate the gp130/STAT3 signalling pathway 5μg/m l Mouse R&D Systems 66
M-CSF (Blocking Antibody)
Macrophage colony-stimulating factor (M-CSF) is critical for osteoblast development and function, although its nuclear targets in osteoclasts are largely unknown 5μg/m l Mouse R&D Systems 66
SDF1 (Blocking Antibody)
Stromal cell derived factor 1 (SDF1, CXCL12) is a small, pro-inflammatory chemoattractant cytokine that regulates leukocyte trafficking by interacting with G protein-coupled receptors. Many embryonic and somatic stem or progenitor cells express the SDF1 receptor CXCR4 and their homing and maintenance regulated by SDF1.
50μg/ ml
Human/ Mouse R&D Systems 66
IGFBP6 (Blocking
Insulin-like growth factor binding protein 6 signals through the IGF-receptor I pathway and is additionally regulated by β-catenin and may be a target of the Wnt 20μg/ ml Human R&D Systems 70
Antibody)
signalling pathway
IL1-R1 (Blocking Antibody)
Interleukin 1 receptor type I, implicated in the NFκβ, and IL1/IL-6 signalling pathways 5μg/m l Mouse R&D Systems 75
FGF-R1 -SU5402 (Chemical Inhibitor)
Inhibits the tyrosine kinase activity of fibroblast growth factor 1 (FGF-R1), and inhibits the aFGF-induced phosphorylation of ERK1 and ERK2. 10μM Human/ Mouse Calbioc hem 76
TNFα (Blocking Antibody)
Tumor necrosis factor alpha is a multifunctional pro-inflammatory cytokine mainly secreted by macrophages. It functions by binding its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR, and is involved in the regulation of cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation.
25μg/ ml Mouse R&D Systems 76
IL-3 (Blocking Antibody)
Interleukin 3 promotes haematopoietic stem cell proliferation and differentiation through binding to IL-3 receptor heterodimers and signalling primarily through the Stat5 and MAPK pathways 2μg/m l Mouse R&D Systems 77
TGFβ 1+2 (Blocking Antibody)
The transforming growth factor beta superfamily consist of multifunctional cytokines involved in diverse cell functions including proliferation, growth, differentiation, motility, and deposition of extracellular matrix. Proteolytic processing of the latent inactive TGFβ complex is required for its activation, mediated through the TGF receptors I and II and stimulates the phosphorylation of Smad 2 and 3.
20μg/ ml
Human/ mouse R&D Systems 79
VEGFR2 (Blocking Antibody)
Vascular endothelial growth factor receptor 2 (VEGFR2, KDR, Flk-1) transduces VEGF induced signalling, proliferation, chemotaxis and sprouting in endothelial cells in vitro, as well as angiogenesis in vivo. VEGFR2 activation leads to recruitment of adaptor proteins, including Shc, GRB2, PI-3 kinase, Nck, SHP-1 and SHP-2, leading to binding of Grb2, PI-3 kinase, PLCγ and Shb.
20μg/ ml Mouse R&D Systems 80
GAS6 (Blocking Antibody)
N-acetylgalactosamine-6-sulfatase is a lysosomal exohydrolase that acts through Axl/Fc receptors and is required for degradation of glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate, mediated through the mTOR/Akt/PI3K signalling pathways. It is also thought to be important in PGC growth and sexual differentiation. 
IGFBP4 (Blocking Antibody)
Insulin-like growth factor binding protein 4 binds both insulin-like growth factors (IGFs) I and II, which circulates in the plasma, prolongs the IGF half-life, and alters signalling through the IGF-receptor I pathway 50μg/ ml Human R&D Systems 95
GM-CSF (Blocking Antibody)
Granulocyte macrophage colony stimulating factor is a cytokine that controls production, differentiation and function of granulocytes and macrophages. The active form of the protein is found extracellularly as a homodimer, but little is known about GM-CSF targets or signalling pathways. A potent inhibitor of human carboxypeptidase M and N, and bradykinin hydrolysis. Carboxypeptidase enzymes hydrolyse C-terminal peptide bonds, and are involved in blood clotting, growth factor production, wound healing and reproduction, where they are involved in protein maturation. 
